Published in

Bentham Science Publishers, Current Protein & Peptide Science, 7(18), p. 715-724, 2017

DOI: 10.2174/1389203717666160311121433

Links

Tools

Export citation

Search in Google Scholar

Structure and function of Fbxo7/PARK15 in Parkinson?s disease

Journal article published in 2015 by Suzanne J. Randle, Heike Laman ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

This is the author accepted manuscript. It is currently under an indefinite embargo pending publication by Bentham Science. ; Fbxo7/PARK15 has well-defined roles, acting as part of a Skp1-Cul1-F box protein (SCF)-type E3 ubiquitin ligase and also has SCF-independent activities. Mutations within FBXO7 have been found to cause an early-onset Parkinson?s disease, and these are found within or near to its functional domains, including its F-box domain (FBD), its proline rich region (PRR), and its ubiquitin-like domain (Ubl). We highlight recent advances in our understanding of Fbxo7 function in Parkinson?s disease, with respect to these mutations and where they occur in the Fbxo7 protein. We hypothesize that many of Fbxo7 functions contribute to its role in PD pathogenesis.